EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Ginsenosides in Modern Pharmaceutics: Mechanisms, Applications, Challenges, and Perspectives

Mingyang Sun, Youduan Li, Ming Zhu, Haoming Luo, Ye Teng

Biomolecules · 26.02.2026 · 16 (3) · 350

DOI: 10.3390/biom16030350 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 26.02.2026. Verfasst von Mingyang Sun und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Changchun University of Chinese Medicine, 1035 Boshuo Road, Changchun 130117, China. Hauptthemen laut MEDLINE: Ginsenosides. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 138 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jilin Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ginsenosides are the primary bioactive constituents of Panax ginseng, exhibiting multiple pharmacological activities, including neuroprotection, antitumor effects, anti-aging properties, and metabolic regulation. In this review, the molecular mechanisms of ginsenosides in treating neurodegenerative diseases, cancer, and metabolic disorders are summarized, and the current status of clinical translational research on ginsenosides in advanced gastric cancer, breast cancer, stroke, and diabetes is introduced, incorporating critical evidence regarding safety assessments and potential toxicity risks. In addition, recent advances in biotransformation and modern preparation technologies are reviewed. Innovative solutions, including nanodelivery systems, structural modifications, and AI-driven formulation design, are systematically discussed to address the current issues, such as low oral bioavailability and limited blood–brain barrier permeability. The future development of ginsenosides continues to face several critical challenges, including a scarcity of high-quality clinical evidence, an incomplete understanding of their mechanisms of action, a dearth of long-term safety data, and variations in quality between batches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GinsenosidesHumansAnimalsPanaxNeoplasmsBlood-Brain BarrierBiological Availability

Stichwörter der Autor:innen

clinical applicationginsenosidesmolecular mechanisms

Substanzen

Ginsenosides

Autor:innen und Institutionen

  • School of Pharmacy, Changchun University of Chinese Medicine, 1035 Boshuo Road, Changchun 130117, China.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Jilin Province

Zitieren

APA

Sun, M., Li, Y., Zhu, M., Luo, H., & Teng, Y. (2026). Ginsenosides in Modern Pharmaceutics: Mechanisms, Applications, Challenges, and Perspectives. Biomolecules, 16(3), 350. https://doi.org/10.3390/biom16030350

Vancouver

Sun M, Li Y, Zhu M, Luo H, Teng Y. Ginsenosides in Modern Pharmaceutics: Mechanisms, Applications, Challenges, and Perspectives. Biomolecules. 2026;16(3):350. doi:10.3390/biom16030350

BibTeX
@article{Sun2026,
  author = {Sun, Mingyang and Li, Youduan and Zhu, Ming and Luo, Haoming and Teng, Ye},
  title = {Ginsenosides in Modern Pharmaceutics: Mechanisms, Applications, Challenges, and Perspectives},
  journal = {Biomolecules},
  year = {2026},
  volume = {16},
  number = {3},
  pages = {350},
  doi = {10.3390/biom16030350}
}
Kostenlos starten →